Pfizer is set to acquire Seagen for $43 billion and create a new oncology division

In a significant move, Pfizer has announced its anticipation of concluding the $43 billion deal to acquire cancer drug maker Seagen by 16 December 2023.

Related Keywords

United States ,American ,Aamir Malik ,Angela Hwang ,Albert Bourla ,Chris Bodhoff ,American Association For Cancer Research ,Merck Kga ,Us Federal Trade Commission ,Merck Kgaa ,Pfizer ,Chief Commercial Officer Angela Hwang ,Chief Business Innovation Officer Aamir Malik ,Alexander De Germay ,Commercial Chief ,American Association ,Trade Commission ,Business News ,Acquisition News ,Seagen ,Fizer Seagen Deal ,Pharmaceutical Industry ,Medicine ,Cancer Research ,Covid 19 ,